1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Morton, C.J.
Pugh, D.J.R.
Campbell, I.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Structure
STRUE6
2005
0969-2126
4
705
714
10.1016/S0969-2126(96)00076-7
8805554
Solution structure and peptide binding of the SH3 domain from human Fyn.
1996
UK
Embo J.
EMJODG
0897
0261-4189
12
2617
Crystal Structure of the SH3 Domain in Human Fyn; Comparison of the Three-Dimensional Structures of SH3 Domains in Tyrosine Kinases and Spectrin
1993
10.2210/pdb1nyf/pdb
pdb_00001nyf
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
N-TERMINAL GS FROM EXPRESSION SYSTEM
7554.108
FYN
2.7.1.112
SH3 DOMAIN, RESIDUES 82 - 148
INS(GS-T82)
1
man
polymer
no
no
TGVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDSIQAEE
TGVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDSIQAEE
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
BL21
9606
Homo sapiens
469008
Escherichia coli BL21(DE3)
BL21 (DE3)
PGEX
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1996-11-08
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1996-04-22
REL
1
BRUNGER
refinement
X-PLOR
3.1
n
1
82
A
n
2
83
A
VAL
84
n
3
VAL
84
A
THR
85
n
4
THR
85
A
LEU
86
n
5
LEU
86
A
PHE
87
n
6
PHE
87
A
VAL
88
n
7
VAL
88
A
ALA
89
n
8
ALA
89
A
LEU
90
n
9
LEU
90
A
TYR
91
n
10
TYR
91
A
ASP
92
n
11
ASP
92
A
TYR
93
n
12
TYR
93
A
GLU
94
n
13
GLU
94
A
ALA
95
n
14
ALA
95
A
ARG
96
n
15
ARG
96
A
THR
97
n
16
THR
97
A
GLU
98
n
17
GLU
98
A
ASP
99
n
18
ASP
99
A
ASP
100
n
19
ASP
100
A
LEU
101
n
20
LEU
101
A
SER
102
n
21
SER
102
A
PHE
103
n
22
PHE
103
A
HIS
104
n
23
HIS
104
A
LYS
105
n
24
LYS
105
A
GLY
106
n
25
GLY
106
A
GLU
107
n
26
GLU
107
A
LYS
108
n
27
LYS
108
A
PHE
109
n
28
PHE
109
A
GLN
110
n
29
GLN
110
A
ILE
111
n
30
ILE
111
A
LEU
112
n
31
LEU
112
A
ASN
113
n
32
ASN
113
A
SER
114
n
33
SER
114
A
SER
115
n
34
SER
115
A
GLU
116
n
35
GLU
116
A
GLY
117
n
36
GLY
117
A
ASP
118
n
37
ASP
118
A
TRP
119
n
38
TRP
119
A
TRP
120
n
39
TRP
120
A
GLU
121
n
40
GLU
121
A
ALA
122
n
41
ALA
122
A
ARG
123
n
42
ARG
123
A
SER
124
n
43
SER
124
A
LEU
125
n
44
LEU
125
A
THR
126
n
45
THR
126
A
THR
127
n
46
THR
127
A
GLY
128
n
47
GLY
128
A
GLU
129
n
48
GLU
129
A
THR
130
n
49
THR
130
A
GLY
131
n
50
GLY
131
A
TYR
132
n
51
TYR
132
A
ILE
133
n
52
ILE
133
A
PRO
134
n
53
PRO
134
A
SER
135
n
54
SER
135
A
ASN
136
n
55
ASN
136
A
TYR
137
n
56
TYR
137
A
VAL
138
n
57
VAL
138
A
ALA
139
n
58
ALA
139
A
PRO
140
n
59
PRO
140
A
VAL
141
n
60
VAL
141
A
n
61
142
A
n
62
143
A
n
63
144
A
n
64
145
A
n
65
146
A
n
66
147
A
n
67
148
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
PHE
109
A
O
PHE
28
A
N
PHE
87
A
N
PHE
6
A
N
VAL
88
A
N
VAL
7
A
O
ALA
139
A
O
ALA
58
A
O
ASN
113
A
O
ASN
32
A
N
GLU
121
A
N
GLU
40
A
N
TRP
120
A
N
TRP
39
A
O
ILE
133
A
O
ILE
52
1
A
THR
82
A
THR
1
1
Y
1
A
GLY
83
A
GLY
2
1
Y
1
A
ASP
142
A
ASP
61
1
Y
1
A
SER
143
A
SER
62
1
Y
1
A
ILE
144
A
ILE
63
1
Y
1
A
GLN
145
A
GLN
64
1
Y
1
A
ALA
146
A
ALA
65
1
Y
1
A
GLU
147
A
GLU
66
1
Y
1
A
GLU
148
A
GLU
67
1
Y
1
A
ARG
96
0.311
SIDE CHAIN
1
A
ARG
123
0.091
SIDE CHAIN
1
A
PHE
103
-165.19
-169.19
1
A
SER
114
-95.97
-72.58
1
A
GLU
116
40.39
-162.58
1
A
ASP
118
170.59
-31.03
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE, MINIMIZED AVERAGE (PROBMAP) STRUCTURE
1
Y
N
A
PRO
134
A
PRO
53
HELX_P
A
TYR
137
A
TYR
56
5
HA
4
PHOSPHOTRANSFERASE
SH3 DOMAIN, POLYPROLINE-BINDING, PHOSPHOTRANSFERASE
FYN_HUMAN
UNP
1
1
P06241
GCVQCKDKEATKLTEERDGSLNQSSGYRYGTDPTPQHYPSFGVTSIPNYNNFHAAGGQGLTVFGGVNSSSHTGTLRTRGG
TGVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDSIQAEEWYFGKLGRKDAER
QLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGYYITTRAQFETLQQLVQHYSERAAGLCCR
LVVPCHKGMPRLTDLSVKTKDVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKL
KHDKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNG
LICKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER
GYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPGENL
81
147
1NYF
82
148
P06241
A
1
1
67
3
3
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
LYS
108
A
LYS
27
A
LEU
112
A
LEU
31
A
LEU
86
A
LEU
5
A
ALA
89
A
ALA
8
A
VAL
138
A
VAL
57
A
PRO
140
A
PRO
59
A
ASN
113
A
ASN
32
A
SER
114
A
SER
33
A
TRP
119
A
TRP
38
A
SER
124
A
SER
43
A
THR
130
A
THR
49
A
ILE
133
A
ILE
52
1
P 1